1 recruiting, 1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Myelinopathy: new trials by email Literature Review of Myelinopathy trials Research Report on Myelinopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound Clemastine Fumarate Combined With Engineered Sound, Clemastine Fumarate Combined With Pink Noise, Placebo Drug With Engineered Sound - Central Auditory Processing Disorder, Hearing Impaired (Partially) | Phase 1 / Phase 2 | Recruiting | University of Colorado, Denver | 344 | 2025-03-31 | 2026-04-30 |
| Association of Plasma Metabolomic Biomarkers with Chronic Ischemic White Matter Injury white matter lesion - Myelinopathy | Unknown | Nanjing First Hospital, Nanjing Medical University | 100 | 2024-06-01 | 2024-09-23 |
Auditory Diseases, Central (1) · Hearing Disorders (1) · Hearing Loss (1) · Hearing Loss, Hidden (1) · Hearing Loss, Noise-Induced (1) · Hearing Loss, Sensorineural (1) · Language Development Disorders (1) · Presbycusis (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Communication Disorders (1) · Ear Diseases (1) · Language Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Otorhinolaryngologic Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Retrocochlear Diseases (1) · Sensation Disorders (1) · Signs and Symptoms (1)
Clemastine (1) · Placebo Effect (1)
Nanjing First Hospital, Nanjing Medical University (1) · University of Colorado, Denver (1)
China (1) · United States (1)
Achim Klug, PhD (1) · Samuel A Budoff, PhD, MS (1) · Ying Zhang, Doctor (1)